The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
N9: Pilot study of novel shortened induction for high-risk neuroblastoma.
 
Brian H. Kushner
No Relationships to Disclose
 
Audrey Mauguen
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - co-inventor of provisional patent Number 63/193,700, filed on 5/27/21; conversion deadline: 5/27/22; named “Soothsayer”, filed by Office of Technology Development, MSKCC
 
Ellen M. Basu
No Relationships to Disclose
 
Fiorella Iglesias Cardenas
No Relationships to Disclose
 
Justin T Gerstle
Stock and Other Ownership Interests - Bristol-Myers Squibb; Merck; Pfizer
 
Kim Kramer
Stock and Other Ownership Interests - Ymabs Therapeutics Inc
Consulting or Advisory Role - Ymabs Therapeutics Inc
Travel, Accommodations, Expenses - Ymabs Therapeutics Inc
 
Shakeel Modak
Consulting or Advisory Role - EUSA Pharma; Illumina; US WorldMeds; Ymabs Therapeutics Inc
Speakers' Bureau - Ymabs Therapeutics Inc
Patents, Royalties, Other Intellectual Property - Two patents pending; no financial benefit